Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	16.53	67.42	57.86
Graham Fair Price	0.52	54.97	54.68
PEG	-105.14	-10.65	-5.19
Price/Book	1.05	3.54	3.51
Price/Cash Flow	41.24	-26.05	18.44
Prices/Earnings	6.95	22.76	21.28
Price/Sales	4.33	7.84	7.51
Price/FCF	41.24	-26.05	18.44
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-3.42	0.32	0.34
Operating Margin	-13.74	0.11	0.12
ROA	-2.00	0.02	0.02
ROE	0.04	0.04	-5.52
ROIC	0.04	0.03	-14.24
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.76	-0.49	55.77
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.07	-0.13	79.16
EPS QOQ	-0.04	-0.02	47.86
FCF QOQ	3.07	-1.74	-43.33
Revenue QOQ	0.04	< 0.005	-88.11
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	7.50	0.00	inf
Days Sales Outstanding (DSO)	111.76	116.57	4.31
Inventory Turnover	12.00	0.00	inf
Debt/Capitalization	0.12	0.10	-9.18
Quick Ratio	1.65	2.30	39.32
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	56.79	58.73	3.42
Cash	9.42	6.97	-25.96
Capex	-0.18	-0.13	26.01
Free Cash Flow	10.80	-7.99	-26.01
Revenue	26.50	26.55	0.17
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.74	2.46	41.25
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-0.38	1.88	393.30
Naive Interpretation	Member

06 - Financial Health · Bad

Rating